January 12-15, 2026 | San Francisco Marriott Marquis, CA
Pinetree Therapeutics is a biotechnology company developing bispecific antibody-based targeted protein degraders through its proprietary AbReptor™ platform to address drug resistance and prevent tumor recurrence.